Trinity Legacy Partners, LLC Abbott Laboratories Transaction History

Trinity Legacy Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	BUY	$102.07 - $123.37 $2,551 - $3,084	25 Added 0.75%	3,353 $365,000
Q1 2022 Apr 13, 2022	SELL	$114.02 - $139.04 $5,130 - $6,256	-45 Reduced 1.33%	3,328 $394,000
Q4 2021 Jan 13, 2022	BUY	$115.53 - $141.46 $117,725 - $144,147	1,019 Added 43.29%	3,373 $475,000
Q3 2021 Oct 12, 2021	BUY	$116.66 - $129.06 $54,596 - $60,400	468 Added 24.81%	2,354 $278,000
Q1 2021 Apr 21, 2021	BUY	$108.84 - $128.23 $205,272 - $241,841	1,886 New	1,886 $235,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Trinity Legacy Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Trinity Legacy Partners, LLC with notifications on news.